Robert Durkin Joins Amin Wasserman Gurnani as Regulatory Group Co-Chair

Amin Wasserman Gurnani (AWG) has announced that Robert Durkin will co-chair the firm's Regulatory Group in Washington, D.C. alongside Rend Al-Mondhiry. Durkin's extensive experience includes 12 years at the FDA, where he served as Acting Director and Deputy Director of the Office of Dietary Supplement Programs (ODSP).

Durkin has contributed significantly to the FDA's dietary supplement programs, participating in multiple agency working groups. His new role at AWG will involve leading complex compliance and enforcement efforts for the firm's diverse clientele.

Managing Partner Ivan Wasserman highlighted Durkin’s addition as a sign of AWG's robust capabilities in handling regulatory matters. Al-Mondhiry expressed enthusiasm about leveraging Durkin's deep FDA insights to benefit the firm's clients.

Durkin is eager to bolster AWG's regulatory practice and praised the firm’s supportive, collaborative environment. He joins a team renowned for its expertise in navigating FDA regulations and representing clients across the health and wellness sector.